A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS
Publication
, Conference
Coleman, RL; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, B; Fujiwara, K; Walker, JL; Spirtos, N; Flynn, PJ; Secord, AA; Cohn, DE ...
Published in: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
September 1, 2018
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
EISSN
1525-1438
ISSN
1048-891X
Publication Date
September 1, 2018
Volume
28
Start / End Page
52 / 52
Publisher
BMJ PUBLISHING GROUP
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Coleman, R. L., Enserro, D., Herzog, T. J., Sabbatini, P., Armstrong, D. K., Kim, B., … Mannel, R. S. (2018). A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS. In INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (Vol. 28, pp. 52–52). BMJ PUBLISHING GROUP.
Coleman, R. L., D. Enserro, T. J. Herzog, P. Sabbatini, D. K. Armstrong, B. Kim, K. Fujiwara, et al. “A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS.” In INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28:52–52. BMJ PUBLISHING GROUP, 2018.
Coleman RL, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim B, et al. A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS. In: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP; 2018. p. 52–52.
Coleman, R. L., et al. “A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS.” INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 28, BMJ PUBLISHING GROUP, 2018, pp. 52–52.
Coleman RL, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim B, Fujiwara K, Walker JL, Spirtos N, Flynn PJ, Secord AA, Cohn DE, Brady MF, Mannel RS. A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP; 2018. p. 52–52.
Published In
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
EISSN
1525-1438
ISSN
1048-891X
Publication Date
September 1, 2018
Volume
28
Start / End Page
52 / 52
Publisher
BMJ PUBLISHING GROUP
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis